The End of “Good Enough”: Why Canadian 3PLs Must Modernize Drug Sample Compliance
by Jean Bedard, CEO, Circulo Pharma For decades, drug sample management has existed in a regulatory grey zone. It occupies a complex intersection of commercial momentum and clinical intent. For decades, the industry relied on what I call “regulatory goodwill”—managing complex distributions through paper manifests and rep signature sheets. But as someone who has managed over […]
The End of “Good Enough”: Why Canadian 3PLs Must Modernize Drug Sample Compliance Read More »